Medcxy · Blog

Aesthetics compliance & data, in practice

Compliance guides, regulatory data explainers and AI workflows — written for medical aesthetics professionals.

Compliance rules, registry data and AI workflows, written for the people who have to make the call every day. Everything here comes from the same rule base and the same registry sources the Medcxy product runs on, with the source visible for every conclusion.

What you'll find here

  • Advertising compliance: high-risk claims, rewrite strategies and platform-by-platform review criteria
  • Regulatory data: how approval works across NMPA, FDA, CE/MDR, PMDA and MFDS, and how to verify a product
  • AI in practice: how compliance review, product Q&A and evidence search work inside a real team
Compliance· Medcxy Compliance Research

What is medical aesthetics ad compliance AI? A working definition for 2026

What compliance AI actually does for aesthetics teams — sentence-level rule checking, risk grading, cited rules and rewrite suggestions — plus six questions to ask any vendor claiming to do it.

#ad compliance#aesthetics marketing#AI review#vendor evaluation
Compliance· Medcxy Compliance Research

Best AI tools for medical aesthetics in 2026: clinic operations vs compliance and regulatory data

A comparison of the tools that actually appear in this category — Pabau, Nextmotion, Clinicminds, Zenoti, Aesthetic Record, AestheticsPro for clinic operations, and IQVIA, Clarivate and Medcxy for compliance and regulatory data — plus how to tell which category you need.

#tool comparison#clinic software#compliance AI#vendor evaluation
Regulatory Data· Medcxy Data Team

In How Many Countries Is a Filler Approved? A Practical Cross-Border Regulatory Comparison (NMPA/FDA/CE/PMDA/MFDS)

Using mainstream hyaluronic acid fillers as an example, we walk through the differences between China's NMPA, the US FDA, EU CE/MDR, Japan's PMDA and Korea's MFDS — and how to quickly verify a product's global approval status.

#NMPA#FDA#EUDAMED#registration#cross-border
Compliance· Medcxy Compliance Research

Medical Aesthetics Ad Compliance: 10 High-Risk Claims to Avoid in 2026

Superlatives, efficacy guarantees, price baiting — a practical guide to the 10 most common violations in medical aesthetics advertising, with rewrite strategies and a platform-by-platform review comparison.

#ad compliance#aesthetics marketing#platform rules

Written by the Medcxy data and compliance teams from public regulations and registry sources. We revisit articles when the underlying rules change.